Previous 10 | Next 10 |
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA) regarding the drug candidate, REMOXY ER. R...
AUSTIN, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a clinical-stage drug development company, today announced two new publications for its drug candidate, REMOXY ER (extended-release oxycodone). The studies are published in Journal of Opioid Management ...
Novume Solutions (NASDAQ: NVMM ) -40% . More news on: NOVUME SOLUTIONS INC, LM Funding America, Inc., China Recycling Energy Corporation, Stocks on the move, , Top stock market news, Read more ...
Pain Therapeutics (PTIE) Q3 2018 Earnings Conference Call October 29, 2018 04:30 am ET Executives Remi Barbier - Chairman, President and Chief Executive Officer Eric Schoen - Chief Financial Officer, Analysts Jason Kolbert - H. C. Wainwright Presentation Operator Gr...
Pain Therapeutics (NASDAQ: PTIE ) Q3 results ($M): Net loss: (1.3) (+51.1%); loss/share: (0.11) ( +72.5%). More news on: Pain Therapeutics, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Pain Therapeutics (NASDAQ: PTIE ): Q3 GAAP EPS of -$0.11. More news on: Pain Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
- Phase IIa Study Initiation On-track for Q4 2018 - AUSTIN, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2018. Net loss was $1.3 million, or...
Context The widespread abuse of opioids has been a national tragedy. It has contributed to the deaths of thousands and led to billions of dollars spent in search of comprehensive remedies. To date, no single solution has been completely effective in reducing the consequences of opioid abuse,...
The Senate will vote next week on the Opioid Crisis Response Act, a lineup of over 70 proposals to fight the opioid crisis following the 50 opioid-related bills that passed the House in June. More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news...
In a statement , FDA Commissioner Scott Gottlieb, M.D. outlines the FDA's many initiatives aimed at addressing the U.S. opioid crisis. Key points: More news on: Endo International plc, Mallinckrodt PLC, INDIVIOR PLC ADR, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Pain Therapeutics Inc. Company Name:
PTIE Stock Symbol:
NASDAQ Market:
Pain Therapeutics Inc. Website:
AUSTIN, Texas, March 27, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, announced a company name change to Cassava Sciences, Inc., effective immediately. The new name was chosen to better reflect the Company’s strategic focus on ...
AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported financial results for the year ended December 31, 2018. Net loss in 2018 was $6.6 million, or $0.61 per share, compared to a net loss in 2017 of $11.9 million, or $1.82 per share. Cash us...
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA) regarding the drug candidate, REMOXY ER. R...